WO2005039380A3 - 悪性黒色腫（メラノーマ）の診断剤 - Google Patents

悪性黒色腫（メラノーマ）の診断剤 Download PDF

Info

Publication number
WO2005039380A3
WO2005039380A3 PCT/JP2004/016374 JP2004016374W WO2005039380A3 WO 2005039380 A3 WO2005039380 A3 WO 2005039380A3 JP 2004016374 W JP2004016374 W JP 2004016374W WO 2005039380 A3 WO2005039380 A3 WO 2005039380A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic agent
malignant melanoma
gpc3
primer
expression
Prior art date
Application number
PCT/JP2004/016374
Other languages
English (en)
French (fr)
Other versions
WO2005039380A2 (ja
WO2005039380A1 (ja
Inventor
Yasuharu Nishimura
Tetsuya Nakatsura
Original Assignee
Kumamoto Tech & Ind Found
Yasuharu Nishimura
Tetsuya Nakatsura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumamoto Tech & Ind Found, Yasuharu Nishimura, Tetsuya Nakatsura filed Critical Kumamoto Tech & Ind Found
Priority to JP2005515066A priority Critical patent/JP4336898B2/ja
Priority to EP04793354A priority patent/EP1684076B1/en
Priority to DE602004018819T priority patent/DE602004018819D1/de
Priority to AU2004283614A priority patent/AU2004283614B2/en
Priority to US10/577,343 priority patent/US7803533B2/en
Publication of WO2005039380A2 publication Critical patent/WO2005039380A2/ja
Publication of WO2005039380A1 publication Critical patent/WO2005039380A1/ja
Publication of WO2005039380A3 publication Critical patent/WO2005039380A3/ja

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

　本発明の目的は、悪性黒色腫（メラノーマ）の新規かつ臨床的に有用な診断剤を提供することである。本発明によれば、ＧＰＣ３に対する抗体、又はＧＰＣ３の発現を検出できるプローブ若しくはプライマーを含む、悪性黒色腫（メラノーマ）の診断剤が提供される。
PCT/JP2004/016374 2003-10-29 2004-10-28 悪性黒色腫（メラノーマ）の診断剤 WO2005039380A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2005515066A JP4336898B2 (ja) 2003-10-29 2004-10-28 悪性黒色腫（メラノーマ）の診断剤
EP04793354A EP1684076B1 (en) 2003-10-29 2004-10-28 Diagnostic method for malignant melanoma
DE602004018819T DE602004018819D1 (de) 2003-10-29 2004-10-28 Diagnoseverfahren für malignes Melanom
AU2004283614A AU2004283614B2 (en) 2003-10-29 2004-10-28 Diagnostic agent for malignant melanoma
US10/577,343 US7803533B2 (en) 2003-10-29 2004-10-28 Diagnostic agent for malignant melanoma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003368725 2003-10-29
JP2003-368725 2003-10-29

Publications (3)

Publication Number Publication Date
WO2005039380A2 WO2005039380A2 (ja) 2005-05-06
WO2005039380A1 WO2005039380A1 (ja) 2005-05-06
WO2005039380A3 true WO2005039380A3 (ja) 2005-06-30

Family

ID=

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646882A (ja) * 1992-03-19 1994-02-22 Behringwerke Ag モノクローナル抗−ガングリオシド抗体、その製造および腫瘍治療剤としての使用
JPH10505481A (ja) * 1994-04-22 1998-06-02 アメリカ合衆国 メラノーマ抗原

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646882A (ja) * 1992-03-19 1994-02-22 Behringwerke Ag モノクローナル抗−ガングリオシド抗体、その製造および腫瘍治療剤としての使用
JPH10505481A (ja) * 1994-04-22 1998-06-02 アメリカ合衆国 メラノーマ抗原

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAKATSURA T, ET AL: "Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 306, 2003, pages 16 - 25, XP002261242 *

Also Published As

Publication number Publication date
US7803533B2 (en) 2010-09-28
WO2005039380A2 (ja) 2005-05-06
EP1684076A4 (en) 2007-08-29
JPWO2005039380A1 (ja) 2007-02-15
JP4336898B2 (ja) 2009-09-30
AU2004283614B2 (en) 2010-05-13
DE602004018819D1 (de) 2009-02-12
EP1684076A2 (en) 2006-07-26
US20080044818A1 (en) 2008-02-21
AU2004283614A1 (en) 2005-05-06
EP1684076B1 (en) 2008-12-31
CN1894587A (zh) 2007-01-10

Similar Documents

Publication Publication Date Title
WO2006002433A3 (en) Methods and reagents for the detection of melanoma
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
WO2006073738A3 (en) Colorimetric sensors constructed of diacetylene materials
WO2002100242A3 (en) Detection of ovarian cancer based upon alpha-haptoglobin levels
AU2003219945A1 (en) Enumeration method of analyte detection
MXPA03006086A (es) Deteccion de analitos.
AU2003248756A1 (en) Microparticle based signal amplification for the detection of analytes
AU2002324881A1 (en) Diagnostic and prognostic tests
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
AU2003289853A1 (en) Methods, device and instrument for detection of analytes
EP1829967A4 (en) METHOD FOR DIAGNOSIS OF MALIGNEM LYMPHOMA AND ASSESSMENT OF THE FORECASTING THEREOF
WO2005039380A3 (ja) 悪性黒色腫（メラノーマ）の診断剤
WO2005039380A1 (ja) 悪性黒色腫（メラノーマ）の診断剤
WO2006031831A3 (en) Methods for the detection of ovarian cancer
AU2003302436A1 (en) Measuring transducer having leak monitoring
WO2003091447A3 (en) D1-1 nucleic acids, polypeptides and related methods
WO2005055804A3 (en) Methods and compositions for diagnosing epithelial cell cancer
AU2003269635A1 (en) An analyzer for the simultaneous enzymatic detection of closely related analytes
GB0226634D0 (en) Undersea hydraulic coupling with radial seals on probe
AU2003243257A1 (en) Assays and kits for detecting the presence of nitriles and/or cyanide
WO2000060119A3 (en) Methods for detecting cancer cells
WO2003080857A3 (en) Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis
AU2003294102A1 (en) Method for continuous detection of an analyte, trifunctional detecting reagent used and detecting device
AU2003258990A1 (en) Sensitizer-labeled analyte detection
AU2003302018A1 (en) Methods of detecting ovarian neoplasia

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480032204.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2005515066

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004793354

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004283614

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004283614

Country of ref document: AU

Date of ref document: 20041028

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004283614

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004793354

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10577343

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10577343

Country of ref document: US